INSPIRE II UPPER AIRWAY STIMULATOR
Inspire Medical Systems · Decision date Apr 30, 2014
What did the FDA approve?
FDA records P130008 as an original PMA application. The recorded decision is approval, dated Apr 30, 2014.
FDA approval order statement
APPROVAL FOR THE INSPIRE UPPER AIRWAY STIMULATION (UAS) SYSTEM, WHICH INCLUDES THE MODEL 3024 IMPLANTABLE PULSE GENERATOR, THE MODEL 4063 STIMULATION LEAD, THE MODEL 4323 SENSING LEAD, THE MODEL 2740PHYSICIAN PROGRAMMER, AND THE MODEL 3032 PATIENT PROGRAMMER. THE DEVICE IS USED TO TREAT A SUBSET OF PATIENTS WITH MODERATE TO SEVERE OBSTRUCTIVE SLEEP APNEA (OSA) (APNEA-HYPOPNEA INDEX [AHI] OF GREATER OR EQUAL TO 20 AND LESS THAN OR EQUAL TO 65). INSPIRE UAS IS USED IN ADULT PATIENTS 22 YEARS OF AGE AND OLDER WHO HAVE BEEN CONFIRMED TO FAIL OR CANNOT TOLERATE POSITIVE AIRWAY PRESSURE (PAP) TREATMENTS (SUCH AS CONTINUOUS POSITIVE AIRWAY PRESSURE [CPAP] OR BILEVEL POSITIVE AIRWAY PRESSURE [BPAP] MACHINES) AND WHO DO NOT HAVE A COMPLETE CONCENTRIC COLLAPSE AT THE SOFT PALATE LEVEL. PAP FAILURE IS DEFINED AS AN INABILITY TO ELIMINATE OSA (AHI OF GREATER THAN 20 DESPITE PAP USAGE) AND PAP INTOLERANCE IS DEFINED AS: 1) INABILITY TO USE PAP (GREATER THAN 5 NIGHTS PER WEEK OF USAGE; USAGE DEFINED AS GREATER THAN 4 HOURS OF USE PER NIGHT); OR 2) UNWILLINGNESS TO USE PAP (FOR EXAMPLE, A PATIENT RETURNS THE PAP SYSTEM AFTER ATTEMPTING TO USE IT).
- Regulatory pathway
- Original PMA
- Clinical specialty
- Anesthesiology
- Decision date
- Apr 30, 2014
Regulatory record facts
- Identifier
- P130008
- Regulatory pathway
- Premarket approval application
- Applicant
- Inspire Medical Systems
- Product code
- MNQ
- Decision code
- APPR
- Decision date
- Apr 30, 2014
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stimulator, hypoglossal nerve, implanted, apnea.
- Applicant
- Inspire Medical Systems
- Product code
- MNQ
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P130008 received
Application receipt date recorded by FDA.
P130008 · FDA decision
APPR
P130008/S146 · Related supplement
Model 3150 IPG
P130008/S147 · Related supplement
Model 3150 IPG
P130008/S144 · Related supplement
INSPIRE II UPPER AIRWAY STIMULATOR
P130008/S148 · Related supplement
Model 4063 Dedicated Tray Sealer
Timeline entries are records held by MedtechLedger for P130008. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P130008
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Model 3150 IPGP130008/S146 | Inspire Medical Systems | PMA supplement | Oct 13, 2026 | FDA |
Model 3150 IPGP130008/S147 | Inspire Medical Systems | PMA supplement | Oct 22, 2026 | FDA |
INSPIRE II UPPER AIRWAY STIMULATORP130008/S144 | Inspire Medical Systems | PMA supplement | Oct 26, 2026 | FDA |
Model 4063 Dedicated Tray SealerP130008/S148 | Inspire Medical Systems | PMA supplement | Nov 5, 2026 | FDA |
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Inspire Medical Systems
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 9700 63rd Ave. N., Suite 200, Maple Grove, MN, 55369
Sources and methodology
- Original FDA record: P130008
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


